Bristol Myers moves to enforce transgenic mice award
US pharmaceuticals company Bristol Myers Squibb has asked a US court to enforce an AAA award it won against Switzerland’s Novartis over royalty payments due for the use of genetically modified laboratory mice.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.